Evidence map›Paper›PMID 42653735›Full record

ReviewPharmaceuticals (Basel, Switzerland)2026

Cannabis and Cannabinoids: The Medical Potential of Cannabidiol in Mental and Neurological Disorders.

Răzvan Șolea, Eugenia Șerban, Sabina Florina Călugăr-Solea, Endre Mathe, Nicoleta Mirela Blebea, Gabriel Hancu, Georgeta Serban

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Răzvan ȘoleaDoctoral School of Biomedical Sciences, Faculty of Medicine and Pharmacy, University of Oradea, 1 Decembrie 10, 410073 Oradea, Romania.
Eugenia ȘerbanDepartment of Environmental Engineering, Faculty of Environmental Protection, University of Oradea, Gen. Magheru 26, 410048 Oradea, Romania.
Sabina Florina Călugăr-SoleaDoctoral School of Biomedical Sciences, Faculty of Medicine and Pharmacy, University of Oradea, 1 Decembrie 10, 410073 Oradea, Romania.
Endre MatheInstitute of Nutrition, Faculty of Agriculture and Food Sciences and Environmental Management, University of Debrecen, Boszormenyi 128, HU-4032 Debrecen, Hungary.ORCID 0000-0002-9011-177X
Nicoleta Mirela BlebeaDepartment of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, "Ovidius" University from Constanța, Căpitan Aviator Al. Șerbănescu 6, 900470 Constanța, Romania.ORCID 0000-0001-9882-5876
Gabriel HancuDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, "George Emil Palade" University of Medicine, Pharmacy, Science and Technology of Târgu Mures, Gh Marinescu 32, 540142 Târgu Mures, Romania.ORCID 0000-0003-2564-9271
Georgeta SerbanDepartment of Pharmaceutical and Therapeutic Chemistry, Faculty of Medicine and Pharmacy, University of Oradea, Nicolae Jiga 29, 410028 Oradea, Romania.ORCID 0000-0002-2926-0995

Funding

University of Oradea
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Alzheimer’s diseaseanxietycannabidiolCannabis sativaepilepsyParkinson’s disease

Identifiers

PMID42653735
PMCPMC13516537

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.